{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:49:35Z","timestamp":1778600975629,"version":"3.51.4"},"reference-count":32,"publisher":"Japan Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1507\/endocrj.ej18-0358","type":"journal-article","created":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T22:05:02Z","timestamp":1558476302000},"page":"731-737","source":"Crossref","is-referenced-by-count":10,"title":["Hyperinsulinemia and thyroid peroxidase antibody in Chinese patients with papillary thyroid cancer"],"prefix":"10.1507","volume":"66","author":[{"given":"Xiaoyan","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Geriatrics, the Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Osteoporosis, Affiliated Zhongshan Hospital of Dalian University, Dalian 116001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ce","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, the Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, the Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, the Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Ito Y, Nikiforov YE, Schlumberger M, Vigneri R (2013) Increasing incidence of thyroid cancer: controversies explored. Nat Rev Endocrinol 9: 178\u2013184.","DOI":"10.1038\/nrendo.2012.257"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R (2013) Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol 2013: 965212.","DOI":"10.1155\/2013\/965212"},{"key":"3","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/thy.2009.0110","volume":"19","author":"DS Cooper","year":"2009","unstructured":"3 Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, et al. (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19: 1167\u20131214.","journal-title":"Thyroid","ISSN":"https:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Roy R, Kouniavsky G, Venkat R, Felger EA, Shiue Z, et al. (2012) The role of preoperative neck ultrasounds to assess lymph nodes in patients with suspicious or indeterminate thyroid nodules. J Surg Oncol 105: 601\u2013605.","DOI":"10.1002\/jso.22115"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, et al. (2009) Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980\u20132005. Cancer Epidemiol Biomarkers Prev 18: 784\u2013791.","DOI":"10.1158\/1055-9965.EPI-08-0960"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Vigneri R, Malandrino P, Vigneri P (2015) The changing epidemiology of thyroid cancer: why is incidence increasing? Curr Opin Oncol 27: 1\u20137.","DOI":"10.1097\/CCO.0000000000000148"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Soliman PT, Wu D, Tortolero-Luna G, Schmeler KM, Slomovitz BM, et al. (2006) Association between adiponectin, insulin resistance, and endometrial cancer. Cancer 106: 2376\u20132381.","DOI":"10.1002\/cncr.21866"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Siddique A, Kowdley KV (2011) Insulin resistance and other metabolic risk factors in the pathogenesis of hepatocellular carcinoma. Clin Liver Dis 15: 281\u2013296.","DOI":"10.1016\/j.cld.2011.03.007"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Djiogue S, Nwabo Kamdje AH, Vecchio L, Kipanyula MJ, Farahna M, et al. (2013) Insulin resistance and cancer: the role of insulin and IGFs. Endocr Relat Cancer 20: R1\u2013R17.","DOI":"10.1530\/ERC-12-0324"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Pisani P (2008) Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Arch Physiol Biochem 114: 63\u201370.","DOI":"10.1080\/13813450801954451"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Hsing AW, Sakoda LC, Chua S Jr (2007) Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr 86: s843\u2013s857.","DOI":"10.1093\/ajcn\/86.3.843S"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Rezzonico JN, Rezzonico M, Pusiol E, Pitoia F, Niepomniszcze H (2009) Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma. Metab Syndr Relat Disord 7: 375\u2013380.","DOI":"10.1089\/met.2008.0062"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Sahin M, Ucan B, Ginis Z, Topaloglu O, Gungunes A, et al. (2013) Vitamin D3 levels and insulin resistance in papillary thyroid cancer patients. Med Oncol 30: 589.","DOI":"10.1007\/s12032-013-0589-5"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Bae MJ, Kim SS, Kim WJ, Yi YS, Jeon YK, et al. (2016) High prevalence of papillary thyroid cancer in Korean women with insulin resistance. Head Neck 38: 66\u201371.","DOI":"10.1002\/hed.23848"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Balkan F, Onal ED, Usluogullari A, Tuzun D, Ozdemir D, et al. (2014) Is there any association between insulin resistance and thyroid cancer?: a case control study. Endocrine 45: 55\u201360.","DOI":"10.1007\/s12020-013-9942-x"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16 Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412\u2013419.","DOI":"10.1007\/BF00280883"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Guay B, Johnson-Obaseki S, McDonald JT, Connell C, Corsten M (2014) Incidence of differentiated thyroid cancer by socioeconomic status and urban residence: Canada 1991\u20132006. Thyroid 24: 552\u2013555.","DOI":"10.1089\/thy.2013.0308"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Belfiore A, La Rosa GL, La Porta GA, Giuffrida D, Milazzo G, et al. (1992) Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med 93: 363\u2013369.","DOI":"10.1016\/0002-9343(92)90164-7"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Konturek A, Barczynski M, Wierzchowski W, Stopa M, Nowak W (2013) Coexistence of papillary thyroid cancer with Hashimoto thyroiditis. Langenbecks Arch Surg 398: 389\u2013394.","DOI":"10.1007\/s00423-012-1021-x"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20 Rezzonico J, Rezzonico M, Pusiol E, Pitoia F, Niepomniszcze H (2008) Introducing the thyroid gland as another victim of the insulin resistance syndrome. Thyroid 18: 461\u2013464.","DOI":"10.1089\/thy.2007.0223"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Perseghin G, Calori G, Lattuada G, Ragogna F, Dugnani E, et al. (2012) Insulin resistance\/hyperinsulinemia and cancer mortality: the cremona study at the 15th year of follow-up. Acta Diabetol 49: 421\u2013428.","DOI":"10.1007\/s00592-011-0361-2"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Ayturk S, Gursoy A, Kut A, Anil C, Nar A, et al. (2009) Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area. Eur J Endocrinol 161: 599\u2013605.","DOI":"10.1530\/EJE-09-0410"},{"key":"23","unstructured":"23 Insulin Resistance Group, Diabetes Society, Chinese Medical Association (2018) Expert guidance on insulin resistance assessment method and application. Chinese Journal of Diabetes 10: 377\u2013385 (In Chinese)."},{"key":"24","unstructured":"24 Zhang MF, Yu HU, Zhou GY (2014) Association of serum antithyroid antibodies with risk of thyroid cancer. Chinese Journal of General Practice 12: 356\u2013358 (In Chinese)."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Kim ES, Lim DJ, Baek KH, Lee JM, Kim MK, et al. (2010) Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules. Thyroid 20: 885\u2013891.","DOI":"10.1089\/thy.2009.0384"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Vasileiadis I, Boutzios G, Charitoudis G, Koukoulioti E, Karatzas T (2014) Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma. Ann Surg Oncol 21: 2725\u20132732.","DOI":"10.1245\/s10434-014-3593-x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC, et al. (2006) Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 91: 4295\u20134301.","DOI":"10.1210\/jc.2006-0527"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Cipollini M, Pastor S, Gemignani F, Castell J, Garritano S, et al. (2013) TPO genetic variants and risk of differentiated thyroid carcinoma in two European populations. Int J Cancer 133: 2843\u20132851.","DOI":"10.1002\/ijc.28317"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 McLeod DS, Watters KF, Carpenter AD, Ladenson PW, Cooper DS, et al. (2012) Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis. J Clin Endocrinol Metab 97: 2682\u20132692.","DOI":"10.1210\/jc.2012-1083"},{"key":"30","unstructured":"30 Tam AA, Ozdemir D, Aydin C, Bestepe N, Ulusoy S, et al. (2018) Association between preoperative thyrotrophin and clinicopathological and aggressive features of papillary thyroid cancer. Endocrine 59: 1\u20138."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Kim HK, Yoon JH, Kim SJ, Cho JS, Kweon SS, et al. (2013) Higher TSH level is a risk factor for differentiated thyroid cancer. Clin Endocrinol (Oxf) 78: 472\u2013477.","DOI":"10.1111\/cen.12027"},{"key":"32","unstructured":"32 He LZ, Zeng TS, Pu L, Pan SX, Xia WF, et al. (2016) Thyroid hormones, autoantibodies, ultrasonography, and clinical parameters for predicting thyroid cancer. Int J Endocrinol 2016: 8215834."}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/66\/8\/66_EJ18-0358\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T10:31:43Z","timestamp":1721298703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/66\/8\/66_EJ18-0358\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej18-0358","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}